- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00819260
Harmonic Scalpel Vs. Electrocautery in Breast Reduction Surgery
May 17, 2013 updated by: Dartmouth-Hitchcock Medical Center
A Randomized Clinical Trial Comparing the Harmonic Scalpel to Electrocautery in Breast Reduction Surgery
Purpose: The aims of this randomized clinical trial are to assess and compare 3 different outcomes in women undergoing breast reduction surgery using two different surgical devices: the Harmonic Scalpel and electrocautery.
The three metrics are:
- the time taken to complete the operation
- drainage volume in the days immediately following surgery,
- patient pain in the days immediately following surgery.
Study Overview
Status
Terminated
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
31
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
New Hampshire
-
Lebanon, New Hampshire, United States, 03756
- Dartmouth Hitchcock Medical Center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Female
Description
Inclusion Criteria:
- Patients are eligible for enrollment if they agree to provide informed consent, can read and speak English, are at least 18 years of age, and are in generally good health.
Exclusion Criteria:
- under 18 years of age
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Harmonic Reduced Breast
harmonic scalpel used to reduce breast on that side
|
harmonic scalpel used to reduce breast on this side
|
Active Comparator: Electrocautery Reduced Breast
Electrocautery (current practice = control) used to reduce breast on that side
|
Electrocautery used to reduce breast on this side
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Time for Operation
Time Frame: day of surgery
|
Time to complete the breast reduction per breast.
|
day of surgery
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Volume of Drainage in Surgical Drains
Time Frame: within one week of surgery
|
An index was created to allow comparison between patients whose drain indwell times were different.
This was created by taking total volume of drainage per breast drain and dividing it by the number of hours the drain was in place.
The units are milliliters per hour.
|
within one week of surgery
|
Pain Level in Surgical Sites
Time Frame: first week after surgery
|
An 11-point visual analog scale was used to obtain subjective pain levels from patients.
0 being no pain and 10 being worst pain imaginable.
|
first week after surgery
|
Hematoma
Time Frame: first day after surgery
|
A collection of blood or uncontrolled bleeding that necessitates a return to the operating room in the first day after surgery.
|
first day after surgery
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Investigators
- Principal Investigator: Carolyn L Kerrigan, MD, DHMC
- Study Director: Todd E Burdette, MD, DHMC
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
March 1, 2009
Primary Completion (Actual)
January 1, 2010
Study Completion (Actual)
February 1, 2010
Study Registration Dates
First Submitted
January 6, 2009
First Submitted That Met QC Criteria
January 7, 2009
First Posted (Estimate)
January 8, 2009
Study Record Updates
Last Update Posted (Estimate)
May 20, 2013
Last Update Submitted That Met QC Criteria
May 17, 2013
Last Verified
May 1, 2013
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 1182DF9
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hyperplasia
-
University of PennsylvaniaFood and Drug Administration (FDA); EUSA Pharma, Inc.; Castleman Disease Collaborative...RecruitingCastleman Disease | Castleman's Disease | Giant Lymph Node Hyperplasia | Angiofollicular Lymph Hyperplasia | Angiofollicular Lymph Node Hyperplasia | Angiofollicular Lymphoid Hyperplasia | GLNH | Hyperplasia, Giant Lymph Node | Lymph Node Hyperplasia, GiantUnited States
-
St. Joseph's Healthcare HamiltonOntario Ministry of Health and Long Term CareCompletedBenign Prostatic HyperplasiaCanada
-
GlaxoSmithKlineCompletedBenign Prostatic Hyperplasia
-
Castleman Disease Collaborative NetworkWithdrawnHyperplasia | Castleman Disease | Castleman's Disease | Giant Lymph Node Hyperplasia | Angiofollicular Lymph Hyperplasia | Angiofollicular Lymph Node Hyperplasia | Angiofollicular Lymphoid Hyperplasia | GLNH | Giant Lymph NodeUnited States
-
Samsung Medical CenterCompletedFocal Nodular HyperplasiaKorea, Republic of
-
Hongguo RongNot yet recruiting
-
SB Istanbul Education and Research HospitalUnknown
-
University of PennsylvaniaCastleman Disease Collaborative NetworkCompletedHyperplasia | Castleman Disease | Castleman's Disease | Giant Lymph Node Hyperplasia | Angiofollicular Lymph Hyperplasia | Angiofollicular Lymphoid Hyperplasia | GLNHUnited States
-
Societatea Romana de Ultrasonografie in Medicina...Institutul Regional de Gastroenterologie & Hepatologie Prof. dr. Octavian... and other collaboratorsUnknownLiver Metastases | Focal Nodular Hyperplasia of Liver | Toxic Liver Disease With Focal Nodular HyperplasiaRomania
-
GCS Ramsay Santé pour l'Enseignement et la RechercheNot yet recruiting
Clinical Trials on Harmonic Scalpel
-
Barretos Cancer HospitalCompletedComplication, PostoperativeBrazil
-
Brazilian Society of Head and Neck SurgeryJohnson & JohnsonUnknown
-
University of CalgaryCompleted
-
University of Lausanne HospitalsCompletedLymphoedema | Lymph Node Dissection | LymphocoeleSwitzerland
-
Sentara Cardiovascular Research InstituteEthicon Endo-SurgeryRecruiting
-
University of Roma La SapienzaCompleted
-
Samsung Medical CenterCompleted
-
Mr Andrew KentCompleted
-
St Andrew's Centre for Plastic SurgeryWithdrawnBreast ReconstructionUnited Kingdom
-
Hippocration General HospitalCompleted